What death panels? FDA begins process to revoke approval for expensive breast cancer drug Avastin

Not a lot of details have emerged yet about the FDA's decison to revoke approval for Avastin, aside from this brief notice at the Washington Post. Yesterday, the Examiner editorialized against this development: On Friday, the Food and Drug Administration could doom thousands of breast cancer victims. The FDA will be...

http://feedproxy.google.com/~r/BeltwayConfidential/~3/9K1kvxHEuHE/what-death-panels-fda-begins-process-revoke-approval-expensive-br

Sent with MobileRSS for iPhone

Sent from my iPhone